Tufts University
OrganisationROR
Trials
Glycemic Impact of NNS Via the Gut Microbiome
No phase, Enrolling by invitation, 2026, 10 people, clinicaltrials.gov
Collaborator, No phase, Recruiting, 2025, 300 people, 23 Apr 2025, clinicaltrials.gov
Phase 2/3, Completed, 2022, 105 people, 6 Sept 2022, clinicaltrials.gov
Collaborator, Phase 4, Completed, 2019, 7 people, 19 Nov 2018, clinicaltrials.gov
Phase 1, Completed, 2016, 12 people, 13 Jan 2017, clinicaltrials.gov
Collaborator, Phase 2, Completed, 2015, 150 people, 19 Aug 2015, clinicaltrials.gov
Collaborator, Phase 3, Terminated, 2015, 91 people, 17 Apr 2015, clinicaltrials.gov
Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation
No phase, Completed, 2013, 20 people, 23 May 2014, clinicaltrials.gov
Spironolactone for Pulmonary Arterial Hypertension
Collaborator, Phase 2, Recruiting, 2014, 70 people, 23 Oct 2012, clinicaltrials.gov
Phase 1, Completed, 2009, 31 people, 16 May 2012, clinicaltrials.gov
Collaborator, Phase 1, Completed, 2010, 10 people, 4 Mar 2011, clinicaltrials.gov
Phase 1, Completed, 2010, 62 people, 29 Dec 2010, clinicaltrials.gov
Collaborator, Phase 3, Completed, 2008, 104 people, 25 Nov 2009, clinicaltrials.gov
Phase 4, Completed, 2008, 41 people, 21 Nov 2008, clinicaltrials.gov
Phase 2, Completed, 2008, 100 people, 4 Nov 2008, clinicaltrials.gov
Collaborator, Phase 2/3, Completed, 2008, 2,745 people, 26 Jun 2008, clinicaltrials.gov
Collaborator, Phase 4, Completed, 2008, 273 people, 24 Jan 2008, clinicaltrials.gov
Phase 4, Completed, 2000, 2,582 people, 28 Sept 2005, clinicaltrials.gov
Phase 2/3, Completed, 2004, 309 people, 4 Jun 2004, clinicaltrials.gov